- K. Fuxe1,
- M. Canals1,3,
- M. Torvinen1,
- D. Marcellino3,
- A. Terasmaa1,
- S. Genedani2,
- G. Leo2,
- D. Guidolin2,9,
- Z. Diaz-Cabiale4,
- A. Rivera5,
- L. Lundstrom6,
- U. Langel6,
- J. Narvaez4,
- S. Tanganelli7,
- C. Lluis3,
- S. Ferré8,
- A. Woods8,
- R. Franco3 &
- …
- L. F. Agnati2
445Accesses
107Citations
Summary.
In 1980/81 Agnati and Fuxe introduced the concept of intramembrane receptor–receptor interactions and presented the first experimental observations for their existence in crude membrane preparations. The second step was their introduction of the receptor mosaic hypothesis of the engram in 1982. The third step was their proposal that the existence of intramembrane receptor–receptor interactions made possible the integration of synaptic (WT) and extrasynaptic (VT) signals. With the discovery of the intramembrane receptor–receptor interactions with the likely formation of receptor aggregates of multiple receptors, so called receptor mosaics, the entire decoding process becomes a branched process already at the receptor level in the surface membrane. Recent developments indicate the relevance of cooperativity in intramembrane receptor–receptor interactions namely the presence of regulated cooperativity via receptor–receptor interactions in receptor mosaics (RM) built up of the same type of receptor (homo-oligomers) or of subtypes of the same receptor (RM type1). The receptor–receptor interactions will to a large extent determine the various conformational states of the receptors and their operation will be dependent on the receptor composition (stoichiometry), the spatial organization (topography) and order of receptor activation in the RM. The biochemical and functional integrative implications of the receptor–receptor interactions are outlined and long-lived heteromeric receptor complexes with frozen RM in various nerve cell systems may play an essential role in learning, memory and retrieval processes. Intramembrane receptor–receptor interactions in the brain have given rise to novel strategies for treatment of Parkinson’s disease (A2A and mGluR5 receptor antagonists), schizophrenia (A2A and mGluR5 agonists) and depression (galanin receptor antagonists). The A2A/D2, A2A/D3 and A2A/mGluR5 heteromers and heteromeric complexes with their possible participation in different types of RM are described in detail, especially in the cortico-striatal glutamate synapse and its extrasynaptic components, together with a postulated existence of A2A/D4 heteromers. Finally, the impact of intramembrane receptor–receptor interactions in molecular medicine is discussed outside the brain with focus on the endocrine, the cardiovascular and the immune systems.
This is a preview of subscription content,log in via an institution to check access.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
Price includes VAT (Japan)
Instant access to the full article PDF.
Similar content being viewed by others
References
S AbdAlla A Abdel-Baset H Lother A el Massiery U Quitterer (2005)ArticleTitleMesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertensionJ Mol Neurosci26 185–192OccurrenceHandle16012192OccurrenceHandle1:CAS:528:DC%2BD2MXmtl2ksrk%3D
S AbdAlla H Lother AM Abdel-tawab U Quitterer (2001a)ArticleTitleThe angiotensin II AT2 receptor is an AT1 receptor antagonistJ Biol Chem276 39721–39726OccurrenceHandle1:CAS:528:DC%2BD3MXotFGit7s%3D
S AbdAlla H Lother A el Massiery U Quitterer (2001b)ArticleTitleIncreased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsivenessNat Med7 1003–1009OccurrenceHandle1:CAS:528:DC%2BD3MXmvFOlsr4%3D
S AbdAlla H Lother U Quitterer (2000)ArticleTitleAT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestrationNature407 94–98OccurrenceHandle10993080OccurrenceHandle1:CAS:528:DC%2BD3cXmsleksrw%3D
GK Ackers ML Doyle D Myers MA Daugherty (1992)ArticleTitleMolecular code for cooperativity in hemoglobinScience255 54–63OccurrenceHandle1553532OccurrenceHandle1:CAS:528:DyaK38Xht1egsb0%3D
L Agnati K Fuxe I Zini P Lenzi T Hökfelt (1980)ArticleTitleAspects on receptor regulation and isoreceptor identificationMed Biol58 182–187OccurrenceHandle6167826OccurrenceHandle1:CAS:528:DyaL3MXisFeitg%3D%3D
L Agnati K Fuxe M Zoli C Rondanini S-O Ögren (1982)ArticleTitleNew vistas on synaptic plasticity: mosaic hypothesis on the engramMed Biol60 183–190OccurrenceHandle6128444OccurrenceHandle1:CAS:528:DyaL38XmtVynsLg%3D
LF Agnati K Fuxe M Ferri F Benfenati S-O Ögren (1981)ArticleTitleA new hypothesis on memory. A possible role of local circuits in the formation of the memory traceMed Biol59 224–229OccurrenceHandle7339294OccurrenceHandle1:STN:280:DyaL387ntFynsw%3D%3D
LF Agnati S Ferré R Burioni A Woods S Genedani R Franco K Fuxe (2005a)ArticleTitleExistence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseasesNeuromol Med7 61–78OccurrenceHandle1:CAS:528:DC%2BD2MXpsVeku7k%3D
LF Agnati S Ferré S Genedani C Franzini AS Woods R Franco S-N Yang K Fuxe (2004a)ArticleTitleThe neurobiological bases of consciousness the multiple mirror network hypothesisAcc Naz Sci Lett Arti di Modena Sez VIII, v. VII fasc.II 317–374
LF Agnati S Ferré G Leo C Lluis EI Canela R Franco K Fuxe (2004b)ArticleTitleOn the molecular basis of the receptor mosaic hypothesis of the engramCell Mol Neurobiol24 501–516OccurrenceHandle1:CAS:528:DC%2BD2cXjtVWls7Y%3D
LF Agnati S Ferré C Lluis R Franco K Fuxe (2003a)ArticleTitleMolecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neuronsPharmacol Rev55 509–550OccurrenceHandle1:CAS:528:DC%2BD3sXnsVynurg%3D
LF Agnati O Franzen S Ferré G Leo R Franco K Fuxe (2003b)ArticleTitlePossible role of intramembrane receptor–receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal gangliaJ Neural Transm Suppl65 1–28
LF Agnati K Fuxe (1984)ArticleTitleNew concepts on the structure of the neuronal networks: the miniaturization and hierarchical organization of the central nervous system. (Hypothesis)Biosci Rep4 93–98OccurrenceHandle6713088OccurrenceHandle1:STN:280:DyaL2c7nvFCmtg%3D%3D
LF Agnati K Fuxe (2000)ArticleTitleVolume transmission as a key feature of information handling in the central nervous system possible new interpretative value of the Turing’s B-type machineProg Brain Res125 3–19OccurrenceHandle11098650OccurrenceHandle1:STN:280:DC%2BD3M%2FmtFCqtg%3D%3D
LF Agnati K Fuxe (2005)ArticleTitleConcluding remarksJ Mol Neurosci26 299–302OccurrenceHandle16012204OccurrenceHandle1:CAS:528:DC%2BD2MXmtl2ks7c%3D
L Agnati K Fuxe K Andersson T Hökfelt L Skirboll F Benfenati N Battistini L Calza (1983a) Possible functional meaning of the coexistence of monoamines a dn peptides in the same neurons. A study on the interactions between cholecystokini-8 and dopamine in the brain G Biggio E Costa GL Gessa PF Spano (Eds) Receptors as supramoledcular entities Pergamon Press New York 61–70
LF Agnati K Fuxe F Benfenati N Battistini A Harfstrand K Tatemoto T Hokfelt V Mutt (1983b)ArticleTitleNeuropeptide Y in vitro selectivity increases the number of alpha 2-adrenergic binding sites in membranes of the medulla oblongata of the ratActa Physiol Scand118 293–295OccurrenceHandle1:CAS:528:DyaL3sXkvF2qurw%3D
L Agnati K Fuxe F Benfenati L Calza N Battistini S Ögren (1983c) Receptor–receptor interactions: possible new mechanisms for the action of some antidepressant drugs E Usdin M Goldstein A Friedhoff A Gergotas (Eds) Frontiers in neuropsychiatric research Macmillan Press London 301–318
LF Agnati K Fuxe F Benfenati I Zini T Hokfelt (1983d)ArticleTitleOn the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of 3H-5-HT binding sitesActa Physiol Scand117 299–301OccurrenceHandle1:CAS:528:DyaL3sXht1ShsLk%3D
LF Agnati K Fuxe S Ferré (2005a)ArticleTitleHow receptor mosaics decode transmitter signals. Possible relevance of cooperativityTrends Biochem Sci30 188–193OccurrenceHandle1:CAS:528:DC%2BD2MXjtVyqsr8%3D
LF Agnati K Fuxe M Ferri F Benfenati S-O Ögren (1981)ArticleTitleA new hypothesis on memory. A possible role of local circuits in the formation of the memory traceMed Biol59 224–229OccurrenceHandle7339294OccurrenceHandle1:STN:280:DyaL387ntFynsw%3D%3D
LF Agnati K Fuxe M Torvinen S Genedani R Franco S Watson GG Nussdorfer G Leo D Guidolin (2005b)ArticleTitleNew methods to evaluate colocalization of fluorophores in immunocytochemical preparations as exemplified by a study on A2A and D2 receptors in Chinese hamster ovary cellsJ Histochem Cytochem53 941–953OccurrenceHandle1:CAS:528:DC%2BD2MXmvVyqt7s%3D
LF Agnati K Fuxe M Zoli EM Pich F Benfenati I Zini M Goldstein (1986)ArticleTitleAspects on the information handling by the central nervous system: focus on cotransmission in the aged rat brainProg Brain Res68 291–301OccurrenceHandle3031730OccurrenceHandle1:CAS:528:DyaL2sXpvF2gsQ%3D%3D
LF Agnati D Guidolin S Genedani S Ferré A Bigiani AS Woods K Fuxe (2005c)ArticleTitleHow proteins come together in the plasma membrane and function in macromolecular assemblies: focus on receptor mosaicsJ Mol Neurosci26 133–154OccurrenceHandle1:CAS:528:DC%2BD2MXmtl2ksrw%3D
LF Agnati G Leo AV Vergoni E Martinez J Hockemeyer C Lluis R Franco K Fuxe S Ferré (2004c)ArticleTitleNeuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson’s diseaseBrain Res Bull64 155–164OccurrenceHandle1:CAS:528:DC%2BD2cXntlemtLo%3D
LF Agnati L Santarossa F Benfenati M Ferri A Morpurgo B Apolloni K Fuxe (2002) Molecular basis of learning and memory: modelling based on receptor mosaics B Apolloni F Kurfes (Eds) From synapses to rules Kluwer Academic/Plenum Publishers New York 165–196
L Agnati L Santarossa S Genedani EI Canela G Leo R Franco K Fuxe (2004d) On the nested hierarchical organization of CNS: basic characteristics of neuronal molecular networks P Erdi A Esposito M Marinaro S Scarpette (Eds) Computational neuroscience: cortical dynamicsSeriesTitleLecture Notes in Computer Science Springer Berlin, Heidelberg New York 24–54
LF Agnati AO Tarakanov S Ferré K Fuxe D Guidolin (2005d)ArticleTitleReceptor–receptor interactions, receptor mosaics, and basic principles of molecular network organization: possible implications for drug developmentJ Mol Neurosci26 193–208OccurrenceHandle1:CAS:528:DC%2BD2MXmtl2ksrY%3D
L Agnati M Zoli E Merlo-Pich F Benfenati K Fuxe (1990)ArticleTitleAspects of neural plasticity in the central nervous system. VII Theoretical aspects of brain communication and communicationNeurochem Int16 479–500OccurrenceHandle1:CAS:528:DyaK3cXkvFWnur4%3DOccurrenceHandle20504587
JA Aguirre J Kehr T Yoshitake FL Liu A Rivera S Fernandez-Espinola B Andbjer G Leo AD Medhurst LF Agnati K Fuxe (2005)ArticleTitleProtection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEPBrain Res1033 216–220OccurrenceHandle15694927OccurrenceHandle1:CAS:528:DC%2BD2MXhtVOru7w%3D
N-E Andén SG Butcher H Corrodi K Fuxe U Ungerstedt (1970)ArticleTitleReceptor activity and turnover of dopamine and noradrenaline after neurolepticsEur J Pharmcol11 303–314
NE Anden A Dahlstrom K Fuxe K Larsson (1966)ArticleTitleFunctional role of the nigro-neostriatal dopamine neuronsActa Pharmacol Toxicol (Copenh)24 263–274OccurrenceHandle1:CAS:528:DyaF28XkvFels7g%3D
MB Andersen K Fuxe T Werge J Gerlach (2002)ArticleTitleThe adenosine A2A receptor agonist CGS 21680 exhibits antipsychotic-like activity in Cebus apella monkeysBehav Pharmacol13 639–644OccurrenceHandle12478214OccurrenceHandle1:CAS:528:DC%2BD38XpsVSrsL4%3D
S Angers A Salahpour M Bouvier (2002)ArticleTitleDimerization: an emerging concept for G protein-coupled receptor ontogeny and functionAnnu Rev Pharmacol Toxicol42 409–435OccurrenceHandle11807178OccurrenceHandle1:CAS:528:DC%2BD38XhvFKntr8%3D
Antonelli T, Fuxe K, Agnati L, Mazzoni E, Tanganelli S, Tomasini MC, Ferraro L (2006) Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson’s disease. Relevance for l-dopa induced dyskinesias. J Neurol Sci Jun 7; [Epub ahead of print]
D Armstrong PG Strange (2001)ArticleTitleDopamine D2 receptor dimer formation: evidence from ligand bindingJ Biol Chem276 22621–22629OccurrenceHandle11278324OccurrenceHandle1:CAS:528:DC%2BD3MXkvVamsbk%3D
RA Bakker P Casarosa H Timmerman MJ Smit R Leurs (2004)ArticleTitleConstitutively active Gq/11-coupled receptors enable signaling by co-expressed G(i/o)-coupled receptorsJ Biol Chem279 5152–5161OccurrenceHandle14610092OccurrenceHandle1:CAS:528:DC%2BD2cXhtFeqsb4%3D
W Bara-Jimenez A Sherzai T Dimitrova A Favit F Bibbiani M Gillespie MJ Morris MM Mouradian TN Chase (2003)ArticleTitleAdenosine A(2A) receptor antagonist treatment of Parkinson’s diseaseNeurology61 293–296OccurrenceHandle12913186OccurrenceHandle1:CAS:528:DC%2BD3sXlslGkur0%3D
L Barki-Harrington AL Bookout G Wang ME Lamb LM Leeb-Lundberg Y Daaka (2003a)ArticleTitleRequirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cellsBiochem J371 581–587OccurrenceHandle1:CAS:528:DC%2BD3sXisleqsL8%3D
L Barki-Harrington LM Luttrell HA Rockman (2003b)ArticleTitleDual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor–receptor interaction in vivoCirculation108 1611–1618OccurrenceHandle1:CAS:528:DC%2BD3sXnsVKrsL4%3D
G Battaglia CL Busceti G Molinaro F Biagioni M Storto F Fornai F Nicoletti V Bruno (2004)ArticleTitleEndogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in miceJ Neurosci24 828–835OccurrenceHandle14749427OccurrenceHandle1:CAS:528:DC%2BD2cXhsFOisbc%3D
I Bellido Z Diaz-Cabiale PA Jimenez-Vasquez B Andbjer AA Mathe K Fuxe (2002)ArticleTitleIncreased density of galanin binding sites in the dorsal raphe in a genetic rat model of depressionNeurosci Lett317 101–105OccurrenceHandle11755250OccurrenceHandle1:CAS:528:DC%2BD38XitFeg
HR Bourne R Nicoll (1993)ArticleTitleMolecular machines integrate coincident synaptic signalsCell Suppl72 65–75
M Bouvier (2001)ArticleTitleOligomerization of G-protein-coupled transmitter receptorsNat Rev Neurosci2 274–286OccurrenceHandle11283750OccurrenceHandle1:CAS:528:DC%2BD3MXis12ktL0%3D
M Canals E Angulo V Casado EI Canela J Mallol F Vinals W Staines B Tinner J Hillion L Agnati K Fuxe S Ferré C Lluis R Franco (2005)ArticleTitleMolecular mechanisms involved in the adenosine A and A receptor-induced neuronal differentiation in neuroblastoma cells and striatal primary culturesJ Neurochem92 337–348OccurrenceHandle15663481OccurrenceHandle1:CAS:528:DC%2BD2MXptFaltw%3D%3D
M Canals J Burgueno D Marcellino N Cabello EI Canela J Mallol L Agnati S Ferré M Bouvier K Fuxe F Ciruela C Lluis R Franco (2004)ArticleTitleHomodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transferJ Neurochem88 726–734OccurrenceHandle14720222OccurrenceHandle1:CAS:528:DC%2BD2cXhtVaitLw%3D
M Canals D Marcellino F Fanelli F Ciruela P de Benedetti SR Goldberg K Neve K Fuxe LF Agnati AS Woods S Ferré C Lluis M Bouvier R Franco (2003)ArticleTitleAdenosine A2A-dopamine D2 receptor–receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transferJ Biol Chem278 46741–46749OccurrenceHandle12933819OccurrenceHandle1:CAS:528:DC%2BD3sXovFKks7k%3D
A Carlsson M Lindqvist (1963)ArticleTitleEffect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brainActa Pharmacol Toxicol (Copenh)20 140–144OccurrenceHandle1:CAS:528:DyaF2cXjsVWhug%3D%3D
DB Carr SR Sesack (2000)ArticleTitleProjections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neuronsJ Neurosci20 3864–3387OccurrenceHandle10804226OccurrenceHandle1:CAS:528:DC%2BD3cXjtlKqsbY%3D
JP Changeux SJ Edelstein (2005)ArticleTitleAllosteric mechanisms of signal transductionScience308 1424–1428OccurrenceHandle15933191OccurrenceHandle1:CAS:528:DC%2BD2MXks1eqtrs%3D
TN Chase F Bibbiani W Bara-Jimenez T Dimitrova JD Oh-Lee (2003)ArticleTitleTranslating A2A antagonist KW6002 from animal models to parkinsonian patientsNeurology61 S107–S111OccurrenceHandle14663022OccurrenceHandle1:CAS:528:DC%2BD3sXptVCltbk%3D
F Ciruela J Burgueno V Casado M Canals D Marcellino SR Goldberg M Bader K Fuxe LF Agnati C Lluis R Franco S Ferré AS Woods (2004)ArticleTitleCombining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope–epitope electrostatic interactions between adenosine A2A and dopamine D2 receptorsAnal Chem76 5354–5363OccurrenceHandle15362892OccurrenceHandle1:CAS:528:DC%2BD2cXmtFOntbs%3D
R Coccurello N Breysse M Amalric (2004)ArticleTitleSimultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in ratsNeuropsychopharmacology29 1451–1461OccurrenceHandle15039773OccurrenceHandle1:CAS:528:DC%2BD2cXlvVSjsbs%3D
PJ Conn G Battaglia MJ Marino F Nicoletti (2005)ArticleTitleMetabotropic glutamate receptors in the basal ganglia motor circuitNat Rev Neurosci6 787–798OccurrenceHandle16276355OccurrenceHandle1:CAS:528:DC%2BD2MXhtV2jsL3I
A Cornea JA Janovick G Maya-Nunez PM Conn (2001)ArticleTitleGonadotropin-releasing hormone receptor microaggregation. Rate monitored by fluorescence resonance energy transferJ Biol Chem276 2153–2158OccurrenceHandle11035030OccurrenceHandle1:CAS:528:DC%2BD3MXotVCmtQ%3D%3D
D de Juan M Mellado JM Rodriguez-Frade P Hernanz-Falcon A Serrano A Del Sol A Valencia AC Martinez AM Rojas (2005)ArticleTitleA framework for computational and experimental methods: Identifying dimerization residues in CCR chemokine receptorsBioinformatics21IssueIDSuppl 2 ii13–ii18OccurrenceHandle16204091OccurrenceHandle1:CAS:528:DC%2BD2MXhtVyrtLvP
Z Diaz-Cabiale Y Hurd D Guidolin UB Finnman M Zoli LF Agnati JJ Vanderhaeghen K Fuxe S Ferré (2001)ArticleTitleAdenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatumNeuroreport12 1831–1834OccurrenceHandle11435907OccurrenceHandle1:CAS:528:DC%2BD3MXltFWqu7g%3D
Z Diaz-Cabiale M Vivo A Del Arco WT O’Connor MK Harte CE Muller E Martinez P Popoli K Fuxe S Ferré (2002)ArticleTitleMetabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptorsNeurosci Lett324 154–158OccurrenceHandle11988350OccurrenceHandle1:CAS:528:DC%2BD38Xjt1Wjsr8%3D
S Fenu A Pinna E Ongini M Morelli (1997)ArticleTitleAdenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned ratsEur J Pharmacol321 143–147OccurrenceHandle9063681OccurrenceHandle1:CAS:528:DyaK2sXhvVWhsb0%3D
S Ferré F Ciruela M Canals D Marcellino J Burgueno V Casado J Hillion M Torvinen F Fanelli P Benedetti Pd SR Goldberg M Bouvier K Fuxe LF Agnati C Lluis R Franco A Woods (2004)ArticleTitleAdenosine A2A-dopamine D2 receptor–receptor heteromers. Targets for neuro-psychiatric disordersParkinsonism Relat Disord10 265–271OccurrenceHandle15196504
S Ferré M Karcz-Kubicha BT Hope P Popoli J Burgueno MA Gutierrez V Casado K Fuxe SR Goldberg C Lluis R Franco F Ciruela (2002)ArticleTitleSynergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal functionProc Natl Acad Sci USA99 11940–11945OccurrenceHandle12189203
S Ferré B Fredholm M Morelli P Popoli K Fuxe (1997)ArticleTitleAdenosine-dopamine receptor–receptor interactions as an integrative mechanism in the basal gangliaTrends Neurosci20 482–487OccurrenceHandle9347617
S Ferré W O’Connor K Fuxe U Ungerstedt (1993)ArticleTitleThe striopallidal neuron: a main locus for adenosine-dopamine interactions in the brainJ Neurosci13 5402–5406OccurrenceHandle8254382
S Ferré W O’Connor P Snaprud U Ungerstedt K Fuxe (1994)ArticleTitleAntagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophreniaNeuroscience63 765–773OccurrenceHandle7898676
S Ferré P Popoli L Giménez-Llort R Rimondini CE Müller I Strömberg SO Ögren K Fuxe (2001)ArticleTitleAdenosine/dopamine interaction: implications for the treatment of Parkinson’s diseaseParkinsonism Rel Disord7 235–241
S Ferré P Popoli R Rimondini R Reggio J Kehr K Fuxe (1999)ArticleTitleAdenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatumNeuropharmacology38 129–140OccurrenceHandle10193904
S Ferré G von Euler B Johansson B Fredholm K Fuxe (1991)ArticleTitleStimulation of high affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranesProc Natl Acad Sci USA88 7238–7241OccurrenceHandle1678519
D Fior P Hedlund K Fuxe (1993)ArticleTitleAutoradiographic evidence for a bradykinin/angiotensin II receptor–receptor interactions in the rat brainNeurosci Lett163 58–62OccurrenceHandle8295734OccurrenceHandle1:CAS:528:DyaK2cXhsVKg
SM Foord SD Topp M Abramo JD Holbrook (2005)ArticleTitleNew methods for researching accessory proteinsJ Mol Neurosci26 265–276OccurrenceHandle16012200OccurrenceHandle1:CAS:528:DC%2BD2MXmtl2ks7s%3D
R Franco V Casado J Mallol S Ferré K Fuxe A Cortes F Ciruela C Lluis EI Canela (2005)ArticleTitleDimer-based model for heptaspanning membrane receptorsTrends Biochem Sci30 360–366OccurrenceHandle15951182OccurrenceHandle1:CAS:528:DC%2BD2MXlvFakt7Y%3D
R Franco S Ferré L Agnati M Torvinen S Gines J Hillion V Casado P Lledo M Zoli C Lluis K Fuxe (2000)ArticleTitleEvidence for adenosine/dopamine receptor interactions: indications for heteromerizationNeuropsychopharmacology23 S50–S59OccurrenceHandle11008067OccurrenceHandle1:CAS:528:DC%2BD3cXmslKqtLo%3D
CM Fraser JC Venter (1982)ArticleTitleThe size of the mammalian lung beta 2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatographyBiochem Biophys Res Commun109 21–29OccurrenceHandle6297476OccurrenceHandle1:CAS:528:DyaL38XmtV2hsLk%3D
BB Fredholm K Fuxe L Agnati (1976)ArticleTitleEffect of some phosphodiesterase inhibitors on central dopamine mechanismsEur J Pharmacol38 31–38OccurrenceHandle182507OccurrenceHandle1:CAS:528:DyaE28XltFKks74%3D
BB Fredholm P Svenningsson (2003)ArticleTitleAdenosine-Dopamine interactions. Development of a concept and some comments on therapeutic possibilitiesNeurology61IssueIDSuppl 6 S5–S9OccurrenceHandle14663001OccurrenceHandle1:CAS:528:DC%2BD3sXptVCltrw%3D
K Fuxe L Agnati (1987) Receptor–receptor interactionsSeriesTitleA new intramembrane integrative mechanism Macmillan Press London
K Fuxe L Agnati F Benfenati M Cimmino S Algeri T Hökfelt V Mutt (1981)ArticleTitleModulation by cholecystokinin of [3H]-spiroperidol binding in rat striatum: Evidence for increased affinity and reduction in the number of binding sitesActa Physiol Scand113 567–569OccurrenceHandle6291324OccurrenceHandle1:STN:280:DyaL3s%2FksVOitA%3D%3D
K Fuxe LF Agnati (1985)ArticleTitleReceptor–receptor interactions in the central nervous system. A new integrative mechanism in synapsesMed Res Rev5 441–482OccurrenceHandle2999530OccurrenceHandle1:STN:280:DyaL28%2FmsVChsw%3D%3D
K Fuxe LF Agnati F Benfenati MF Celani I Zini M Zoli V Mutt (1983a)ArticleTitleEvidence for the existence of receptor–receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptidesJ Neural Transm18 165–179OccurrenceHandle1:CAS:528:DyaL3sXlslSgsrg%3D
K Fuxe L Agnati MF Celani F Benfenati K Andersson J Collins (1983b) Studies on excitatory amino acid receptors and their interactions and regulation of pre and postsynaptic dopaminergic mechanisms in the rat telencephalon K Fuxe P Roberts R Schwarcz (Eds) Excitotoxins MacMillan Press London 138–156
K Fuxe LF Agnati A Harfstrand K Andersson F Mascagni M Zoli M Kalia N Battistini F Benfenati T Hokfeltet al. (1986a)ArticleTitleStudies on peptide comodulator transmission. New perspective on the treatment of disorders of the central nervous systemProg Brain Res66 341–368OccurrenceHandle1:CAS:528:DyaL2sXmtlI%3D
Fuxe K, Agnati L, Härfstrand A, Janson A, Neumeyer A, Andersson K, Ruggeri M, Zoli M, Goldstein M (1986b) Morphofunctional studies on the neuropeptide Y/adrenaline costoring terminal systems in the dorsal cardiovascular region of the medulla oblongata. Focus on receptor–receptor interactions in cotransmission. In: Hökfelt T, Fuxe K, Pernow B (eds) Prog in Brain Res, Vol. 68. Elsevier, Amsterdam, pp 303–320
K Fuxe LF Agnati K Jacobsen J Hillion M Canals M Torvinen B Tinner-Staines W Staines D Rosin A Terasmaa P Popoli G Leo V Vergoni C Lluis F Ciruela R Franco S Ferré (2003)ArticleTitleReceptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson’s diseaseNeurology61 S19–S23OccurrenceHandle14663004OccurrenceHandle1:CAS:528:DC%2BD3sXptVCltrg%3D
K Fuxe L Agnati S Ögren K Andersson F Benfenati (1983c) Neurobiology of central monoamine neurotransmission: Functional neuroanatomy and noradrenaline and 5-hydroxytryptamine involvement in learning and memory R Caputto C Marsan (Eds) Neural transmission, learning and memory Raven Press New York 237–255
K Fuxe MF Celani M Martire I Zini M Zoli LF Agnati (1984)ArticleTitlel-Glutamate reduces the affinity of 3H-N-propylnorapomorphine binding sites in striatal membranesEur J Pharmacol100 127–130OccurrenceHandle6144551OccurrenceHandle1:CAS:528:DyaL2cXktFyjsrw%3D
K Fuxe S Ferré M Canals M Torvinen A Terasmaa D Marcellino SR Goldberg W Staines KX Jacobsen C Lluis AS Woods LF Agnati R Franco (2005)ArticleTitleAdenosine A2A and dopamine D2 heteromeric receptor complexes and their functionJ Mol Neurosci26 209–220OccurrenceHandle16012194OccurrenceHandle1:CAS:528:DC%2BD2MXmtl2ksrc%3D
Fuxe K, Ferré S, Franco R, Agnati L (2006) Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav (in press)
K Fuxe S Ferré M Zoli LF Agnati (1998)ArticleTitleIntegrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal gangliaBrain Res Rev26 258–273OccurrenceHandle9651540OccurrenceHandle1:CAS:528:DyaK1cXjs1art7Y%3D
K Fuxe A Harfstrand L Agnati M Kalia B Fredholm D Ganten (1987)ArticleTitleCentral catecholamine-neuropeptide Y interactions at the pre- and post-synaptic level in cardiovascular centersJ Cardiovasc Pharmacol10 1–13
K Fuxe P Hedlund Gv Euler K Lundgren M Martire S Ögren P Eneroth L Agnati (1991) Galanin/5-HT interactions in the rat central nervous system. Relevance for depression T Hökfelt T Bartfai D Jacobowitz D Ottoson (Eds) GalaninSeriesTitleA new multifunctional peptide in the neuroendocrine systemNumberInSeries58 Macmillan London 221–235
K Fuxe P Manger S Genedani L Agnati (2006)ArticleTitleThe nigrostriatal DA pathway and Parkinson’s diseaseJ Neural Transm Suppl70 71–83OccurrenceHandle17017512OccurrenceHandle1:CAS:528:DC%2BD28Xht1WjsrjFOccurrenceHandle10.1007/978-3-211-45295-0_13
K Fuxe I Strömberg P Popoli R Rimondini-Giorgini M Torvinen SO Ögren R Franco LF Agnati S Ferré (2001) Adenosine receptors and Parkinson’s Disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum D Calne S Calne (Eds) Parkinson’s diseaseNumberInSeries86 Lippincott Williams & Wilkins Philadelphia 345–353
K Fuxe U Ungerstedt (1974)ArticleTitleAction of caffeine and theophyllamine on supersensitive dopamine receptors: Considerable enhancement of receptor response to treatment with dopa and dopamine receptor agonistsMed Biol52 48–54OccurrenceHandle4157329OccurrenceHandle1:CAS:528:DyaE2cXksVGnsLY%3D
K Fuxe U Ungerstedt (1976)ArticleTitleAntiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH–DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviourPharmacol Ther [B]2 41–47OccurrenceHandle1:CAS:528:DyaE28XhsVCnsbk%3D
K Fuxe G von Euler LF Agnati SO Ögren (1988a)ArticleTitleGalanin selectively modulates 5-hydroxytryptamine 1A receptors in the rat ventral limbic cortexNeurosci Lett85 163–167OccurrenceHandle1:CAS:528:DyaL1cXht1Cqsr8%3D
K Fuxe S Ögren L Agnati J-Å Gustafsson G Jonsson (1977)ArticleTitleOn the mechanism of action of the antidepressant drugs amitriptyline and nortriptyline. Evidence for 5-hydroxytryptamine receptor blocking activityNeurosci Lett6 339–343OccurrenceHandle1:CAS:528:DyaE1cXhvVaktrc%3DOccurrenceHandle19605076
K Fuxe S Ögren A Jansson A Cintra A Härfstrand L Agnati (1988b)ArticleTitleIntraventricular injections of galanin reduces 5-HT metabolism in the ventral limbic cortex, the hippocampal formation and the fronto-parietal cortex of the male ratActa Physiol Scand133 579–581OccurrenceHandle1:CAS:528:DyaL1cXlt1art78%3D
PS Goldman-Rakic SA Castner TH Svensson LJ Siever GV Williams (2004)ArticleTitleTargeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunctionPsychopharmacology (Berl)174 3–16OccurrenceHandle1:CAS:528:DC%2BD2cXmvVahtL0%3D
Gozes I (ed) (2005) Receptor–receptor interactions among heptaspanning membrane receptors: From structure to function. J Mol Neurosci 26: 109–303
AM Graybiel (2005)ArticleTitleThe basal ganglia: learning new tricks and loving itCurr Opin Neurobiol15 638–644OccurrenceHandle16271465OccurrenceHandle1:CAS:528:DC%2BD2MXht1Ggu7fP
W Hauber M Koch (1997)ArticleTitleAdenosine A2A receptors in the nucleus accumbens modulate prepulse inhibition of the startle responseNeuroreport8 1515–1518OccurrenceHandle9172165OccurrenceHandle1:CAS:528:DyaK2sXjvVOhu74%3D
RA Hauser JP Hubble DD Truong (2003)ArticleTitleRandomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PDNeurology61 297–303OccurrenceHandle12913187OccurrenceHandle1:CAS:528:DC%2BD3sXlslGkurs%3D
RD Hawkins ER Kandel SA Sigelbaum (1993)ArticleTitleLearning to modulate transmitter release: Themes and variations in synaptic plasticityAnn Rev Neurosci16 625–665OccurrenceHandle8096376OccurrenceHandle1:CAS:528:DyaK3sXitlSntr4%3D
D Hebb (1949) The organization of behavior Wiley New York
P Hedlund U-B Finnman N Yanaihara K Fuxe (1994)ArticleTitleGalanin-(1–15), but not galanin-(1–29), modulates 5-HT1A receptors in the dorsal hippocampus of the rat brain: possible existence of galanin receptor subtypesBrain Res634 163–167OccurrenceHandle7512426OccurrenceHandle1:CAS:528:DyaK2cXps1Crug%3D%3D
P Hedlund K Fuxe (1991)ArticleTitleChronic imipramine treatment increases the affinity of [125I]galanin binding sites in the tel- and diencephalon of the rat and alters the 5-HT1A/galanin receptor interactionActa Physiol Scand141 137–138OccurrenceHandle1711266OccurrenceHandle1:CAS:528:DyaK3MXltVKmurY%3DOccurrenceHandle10.1111/j.1748-1716.1991.tb09058.x
P Hedlund G von Euler K Fuxe (1991)ArticleTitleActivation of 5-hydroxytryptamine 1A receptors increases the affinity of galanin receptors in di- and telencephalic areas of the ratBrain Res560 251–259OccurrenceHandle1836971OccurrenceHandle1:CAS:528:DyaK3MXmslWgsbo%3D
P Hedlund N Yanaihara K Fuxe (1992)ArticleTitleEvidence for specific N-terminal galanin fragment binding sites in the rat brainEur J Pharmacol224 203–205OccurrenceHandle1281778OccurrenceHandle1:CAS:528:DyaK3sXntl2rug%3D%3D
PB Hedlund S Huitron-Resendiz SJ Henriksen JG Sutcliffe (2005)ArticleTitle5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep patternBiol Psychiatry58 831–837OccurrenceHandle16018977OccurrenceHandle1:CAS:528:DC%2BD2MXht1Ght7jJ
LK Heisler HM Chu TJ Brennan JA Danao P Bajwa LH Parsons LH Tecott (1998)ArticleTitleElevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant miceProc Natl Acad Sci USA95 15049–15054OccurrenceHandle9844013OccurrenceHandle1:CAS:528:DyaK1cXotVGls7c%3D
J Hillion M Canals M Torvinen V Casado R Scott A Terasmaa A Hansson S Watson ME Olah J Mallol EI Canela M Zoli LF Agnati CF Ibanez C Lluis R Franco S Ferré K Fuxe (2002)ArticleTitleCoaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptorsJ Biol Chem277 18091–18097OccurrenceHandle11872740OccurrenceHandle1:CAS:528:DC%2BD38XktVCmsrc%3D
EK Jaffe (2005)ArticleTitleMorpheeins – a new structural paradigm for allosteric regulationTrends Biochem Sci30 490–497OccurrenceHandle16023348OccurrenceHandle1:CAS:528:DC%2BD2MXpsVWitb0%3D
JA Janovick PM Conn (1996)ArticleTitleGonadotropin releasing hormone agonist provokes homologous receptor microaggregation: an early event in seven-transmembrane receptor mediated signalingEndocrinology137 3602–3605OccurrenceHandle8754794OccurrenceHandle1:CAS:528:DyaK28XksVCgsrk%3D
JD Jentsch RH Roth (1999)ArticleTitleThe neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophreniaNeuropsychopharmacology20 201–225OccurrenceHandle10063482OccurrenceHandle1:CAS:528:DyaK1MXhsleisrs%3D
A Kachroo LR Orlando DK Grandy JF Chen AB Young MA Schwarzschild (2005)ArticleTitleInteractions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian miceJ Neurosci25 10414–10419OccurrenceHandle16280580OccurrenceHandle1:CAS:528:DC%2BD2MXht1KgtbrE
T Kamiya O Saitoh K Yoshioka H Nakata (2003)ArticleTitleOligomerization of adenosine A2A and dopamine D2 receptors in living cellsBiochem Biophys Res Commun306 544–549OccurrenceHandle12804599OccurrenceHandle1:CAS:528:DC%2BD3sXksVyktLg%3D
T Kanda MJ Jackson LA Smith RK Pearce J Nakamura H Kase Y Kuwana P Jenner (1998)ArticleTitleAdenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeysAnn Neurol43 507–513OccurrenceHandle9546333OccurrenceHandle1:CAS:528:DyaK1cXisFyisbw%3D
S Kapur D Mamo (2003)ArticleTitleHalf a century of antipsychotics and still a central role for dopamine D2 receptorsProg Neuropsychopharmacol Biol Psychiatry27 1081–1090OccurrenceHandle14642968OccurrenceHandle1:CAS:528:DC%2BD3sXpt1SgtL4%3D
A Kaufmann (1993) The origins of order Oxford University Press New York
JA Kearney RL Albin (1995)ArticleTitleAdenosine A2 receptor-mediated modulation of contralateral rotation induced by metabotropic glutamate receptor activationEur J Pharmacol287 115–120OccurrenceHandle8749024OccurrenceHandle1:STN:280:DyaK28zkt1OnsQ%3D%3D
J Kehr T Yoshitake FH Wang H Razani L Gimenez-Llort A Jansson M Yamaguchi SO Ogren (2002)ArticleTitleGalanin is a potent in vivo modulator of mesencephalic serotonergic neurotransmissionNeuropsychopharmacology27 341–356OccurrenceHandle12225692OccurrenceHandle1:CAS:528:DC%2BD38XmvVWru7k%3D
T Kenakin (2003)ArticleTitleLigand-selective receptor conformations revisited: the promise and the problemTrends Pharmacol Sci24 346–354OccurrenceHandle12871667OccurrenceHandle1:CAS:528:DC%2BD3sXltl2gt7Y%3D
C Le Moine P Svenningsson BB Fredholm B Bloch (1997)ArticleTitleDopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expressionJ Neurosci17 8038–8040OccurrenceHandle9315922OccurrenceHandle1:CAS:528:DyaK2sXms1ensr8%3D
C Lee IJ Ji TH Ji (2002)ArticleTitleUse of defined-function mutants to access receptor–receptor interactionsMethods27 318–323OccurrenceHandle12217647OccurrenceHandle1:CAS:528:DC%2BD38Xms1Wrur4%3D
FJ Lee S Xue L Pei B Vukusic N Chery Y Wang YT Wang HB Niznik XM Yu F Liu (2002)ArticleTitleDual regulation of NMDA receptor functions by direct protein–protein interactions with the dopamine D1 receptorCell111 219–230OccurrenceHandle12408866OccurrenceHandle1:CAS:528:DC%2BD38Xotlahsro%3D
SP Lee CH So AJ Rashid G Varghese R Cheng AJ Lanca BF O’Dowd SR George (2004)ArticleTitleDopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signalJ Biol Chem279 35671–35678OccurrenceHandle15159403OccurrenceHandle1:CAS:528:DC%2BD2cXmsl2hsb4%3D
SP Lee Z Xie G Varghese T Nguyen BF O’Dowd SR George (2000)ArticleTitleOligomerization of dopamine and serotonin receptorsNeuropsychopharmacology23 S32–S40OccurrenceHandle11008065OccurrenceHandle1:CAS:528:DC%2BD3cXmslKqtLw%3D
RJ Lefkowitz (2004)ArticleTitleHistorical review: a brief history and personal retrospective of seven-transmembrane receptorsTrends Pharmacol Sci25 413–422OccurrenceHandle15276710OccurrenceHandle1:CAS:528:DC%2BD2cXmtVaht7k%3D
RJ Lefkowitz (2005)ArticleTitleSummary of Wenner-Gren international symposium receptor–receptor interactions among heptaspanning membrane receptors: from structure to functionJ Mol Neurosci26 293–294OccurrenceHandle16012202OccurrenceHandle1:CAS:528:DC%2BD2MXmtl2ks7k%3D
RJ Lefkowitz S Cotecchia P Samama T Costa (1993)ArticleTitleConstitutive activity of receptors coupled to guanine nucleotide regulatory proteinsTrends Pharmacol Sci14 303–307OccurrenceHandle8249148OccurrenceHandle1:CAS:528:DyaK3sXlslCltr0%3D
LE Limbird RJ Lefkowitz (1976)ArticleTitleNegative cooperativity among beta-adrenergic receptors in frog erythrocyte membranesJ Biol Chem251 5007–5014OccurrenceHandle956174OccurrenceHandle1:CAS:528:DyaE28XlsFCiurk%3D
LE Limbird PD Meyts RJ Lefkowitz (1975)ArticleTitleBeta-adrenergic receptors: evidence for negative cooperativityBiochem Biophys Res Commun64 1160–1168OccurrenceHandle1137592OccurrenceHandle1:CAS:528:DyaE2MXlt1KlsLY%3D
F Liu Q Wan ZB Pristupa XM Yu YT Wang HB Niznik (2000)ArticleTitleDirect protein–protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptorsNature403 274–280OccurrenceHandle10659839OccurrenceHandle1:CAS:528:DC%2BD3cXns1Cisw%3D%3D
JJ Maguire AP Davenport (2005)ArticleTitleRegulation of vascular reactivity by established and emerging GPCRsTrends Pharmacol Sci26 448–454OccurrenceHandle16054240OccurrenceHandle1:CAS:528:DC%2BD2MXpslCgsLw%3D
MJ Marino O Valenti PJ Conn (2003)ArticleTitleGlutamate receptors and Parkinson’s disease: opportunities for interventionDrugs Aging20 377–397OccurrenceHandle12696997OccurrenceHandle1:CAS:528:DC%2BD3sXotVeksbg%3D
FH Marshall KA Jones K Kaupmann B Bettler (1999)ArticleTitleGABAB receptors – the first 7TM heterodimersTrends Pharmacol Sci20 396–399OccurrenceHandle10498952OccurrenceHandle1:CAS:528:DyaK1MXmsVWhtrY%3D
LM McLatchie NJ Fraser MJ Main A Wise J Brown N Thompson R Solari MG Lee SM Foord (1998)ArticleTitleRAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptorNature393 333–339OccurrenceHandle9620797OccurrenceHandle1:CAS:528:DyaK1cXjsFyjt78%3D
M Mellado JM Rodriguez-Frade AJ Vila-Coro S Fernandez A Martin de Ana DR Jones JL Toran AC Martinez (2001)ArticleTitleChemokine receptor homo- or heterodimerization activates distinct signaling pathwaysEMBO J20 2497–2507OccurrenceHandle11350939OccurrenceHandle1:CAS:528:DC%2BD3MXktFegu7k%3D
A Meyer-Lindenberg RS Miletich PD Kohn G Esposito RE Carson M Quarantelli DR Weinberger KF Berman (2002)ArticleTitleReduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophreniaNat Neurosci5 267–271OccurrenceHandle11865311OccurrenceHandle1:CAS:528:DC%2BD38XhvFKjtro%3D
G Milligan (2004)ArticleTitleG protein-coupled receptor dimerization: function and ligand pharmacologyMol Pharmacol66 1–7OccurrenceHandle15213289OccurrenceHandle1:CAS:528:DC%2BD2cXlsVOjtbY%3D
M Morelli J Wardas (2001)ArticleTitleAdenosine A(2A) receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson’s diseaseNeurotox Res3 545–556OccurrenceHandle15111244OccurrenceHandle1:CAS:528:DC%2BD38XpsVc%3DOccurrenceHandle10.1007/BF03033210
S Murase JM Mathe J Grenhoff TH Svensson (1993)ArticleTitleEffects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localizationJ Neural Transm Gen Sect91 13–25OccurrenceHandle8452684OccurrenceHandle1:CAS:528:DyaK3sXksVSktrc%3D
H Nakata K Yoshioka T Kamiya H Tsuga K Oyanagi (2005)ArticleTitleFunctions of heteromeric association between adenosine and P2Y receptorsJ Mol Neurosci26 233–238OccurrenceHandle16012196OccurrenceHandle1:CAS:528:DC%2BD2MXmtl2ks78%3D
GY Ng BF O’Dowd M Caron M Dennis MR Brann SR George (1994)ArticleTitlePhosphorylation and palmitoylation of the human D2L dopamine receptor in Sf9 cellsJ Neurochem63 1589–1595OccurrenceHandle7931316OccurrenceHandle1:CAS:528:DyaK2cXmsVOjs7k%3DOccurrenceHandle10.1046/j.1471-4159.1994.63051589.x
SM Nicola J Surmeier RC Malenka (2000)ArticleTitleDopaminergic modulation of neuronal excitability in the striatum and nucleus accumbensAnnu Rev Neurosci23 185–215OccurrenceHandle10845063OccurrenceHandle1:CAS:528:DC%2BD3cXjs1Gmsr8%3D
EA Nimchinsky PR Hof WG Janssen JH Morrison C Schmauss (1997)ArticleTitleExpression of dopamine D3 receptor dimers and tetramers in brain and in transfected cellsJ Biol Chem272 29229–29237OccurrenceHandle9361002OccurrenceHandle1:CAS:528:DyaK2sXnsVOht70%3D
S-O Ögren K Fuxe LF Agnati J-Å Gustafsson G Jonsson AC Holm (1979)ArticleTitleReevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugsJ Neural Transm46 85–103OccurrenceHandle574536
G Olias C Viollet H Kusserow J Epelbaum W Meyerhof (2004)ArticleTitleRegulation and function of somatostatin receptorsJ Neurochem89 1057–1091OccurrenceHandle15147500OccurrenceHandle1:CAS:528:DC%2BD2cXkvFOktLY%3D
K Ossowska J Konieczny S Wolfarth J Wieronska A Pilc (2001)ArticleTitleBlockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in ratsNeuropharmacology41 413–420OccurrenceHandle11543761OccurrenceHandle1:CAS:528:DC%2BD3MXmsFWkt7c%3D
S Paglin JD Jamieson (1982)ArticleTitleCovalent crosslinking of angiotensin II to its binding sites in rat adrenal membranesProc Natl Acad Sci USA79 3739–3743OccurrenceHandle6285362OccurrenceHandle1:CAS:528:DyaL38Xktlemsro%3D
CL Parks PS Robinson E Sibille T Shenk M Toth (1998)ArticleTitleIncreased anxiety of mice lacking the serotonin1A receptorProc Natl Acad Sci USA95 10734–10739OccurrenceHandle9724773OccurrenceHandle1:CAS:528:DyaK1cXlvFWgsbY%3D
RC Patel U Kumar DC Lamb JS Eid M Rocheville M Grant A Rani T Hazlett SC Patel E Gratton YC Patel (2002)ArticleTitleLigand binding to somatostatin receptors induces receptor-specific oligomer formation in live cellsProc Natl Acad Sci USA99 3294–3299OccurrenceHandle11880655OccurrenceHandle1:CAS:528:DC%2BD38Xit1Cqtrw%3D
SJ Peroutka SH Snyder (1979)ArticleTitleMultiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidolMol Pharmacol16 687–699OccurrenceHandle530254OccurrenceHandle1:CAS:528:DyaL3cXhsF2rug%3D%3D
M Pfeiffer T Koch H Schroder M Klutzny S Kirscht HJ Kreienkamp V Hollt S Schulz (2001)ArticleTitleHomo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A)J Biol Chem276 14027–14036OccurrenceHandle11134004OccurrenceHandle1:CAS:528:DC%2BD3MXjt12rs7s%3D
M Pfeiffer T Koch H Schroder M Laugsch V Hollt S Schulz (2002)ArticleTitleHeterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitizationJ Biol Chem277 19762–19772OccurrenceHandle11896051OccurrenceHandle1:CAS:528:DC%2BD38XksVWksL8%3D
A Pinna G di Chiara J Wardas M Morelli (1996)ArticleTitleBlockade of A2A adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated ratsEur J Neurosci8 1176–1181OccurrenceHandle8752587OccurrenceHandle1:STN:280:DyaK28zisFGmuw%3D%3D
A Pinna J Wardas A Cozzolino M Morelli (1999)ArticleTitleInvolvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidolNeuropsychopharmacology20 44–51OccurrenceHandle9885784OccurrenceHandle1:CAS:528:DyaK1cXnvVOms7c%3D
A Pintor D Quarta A Pezzola R Reggio P Popoli (2001)ArticleTitleSCH 58261 (an adenosine A(2A) receptor antagonist) reduces, only at low doses, K(+)-evoked glutamate release in the striatumEur J Pharmacol421 177–180OccurrenceHandle11516434OccurrenceHandle1:CAS:528:DC%2BD3MXksVGqsrw%3D
AE Pollack JS Fink (1996)ArticleTitleSynergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned ratsBrain Res743 124–130OccurrenceHandle9017239OccurrenceHandle1:CAS:528:DyaK28XntlKrtLg%3D
P Popoli A Pezzola M Torvinen R Reggio A Pintor L Scarchilli K Fuxe S Ferré (2001)ArticleTitleThe selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2A) receptorsNeuropsychopharmacology25 505–513OccurrenceHandle11557164OccurrenceHandle1:CAS:528:DC%2BD3MXms12msbc%3D
U Quitterer H Lother S Abdalla (2004)ArticleTitleAT1 receptor heterodimers and angiotensin II responsiveness in preeclampsiaSemin Nephrol24 115–119OccurrenceHandle15017523OccurrenceHandle1:CAS:528:DC%2BD2cXjsVGnur0%3D
H Razani Z Diaz-Cabiale K Fuxe SO Ögren (2000)ArticleTitleIntraventricular galanin produces a time-dependent modulation of 5-HT1A receptors in the dorsal raphe of the ratNeuroReport11 3943–3948OccurrenceHandle11192606OccurrenceHandle1:CAS:528:DC%2BD3MXltFKgug%3D%3D
R Rimondini S Ferré L Giménez-Llort SO Ögren K Fuxe (1998)ArticleTitleDifferential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in ratsEur J Pharmacol347 153–158OccurrenceHandle9653875OccurrenceHandle1:CAS:528:DyaK1cXivVGjt7k%3D
R Rimondini S Ferré SO Ögren K Fuxe (1997)ArticleTitleAdenosine A2A agonists: A potential new type of atypical antipsychoticNeuropsychopharmacology17 82–91OccurrenceHandle9252983OccurrenceHandle1:CAS:528:DyaK2sXlt1Omu7k%3D
A Rivera B Cuellar FJ Giron DK Grandy A de la Calle R Moratalla (2002)ArticleTitleDopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatumJ Neurochem80 219–229OccurrenceHandle11902112OccurrenceHandle1:CAS:528:DC%2BD38XptVyquw%3D%3D
M Rocheville DC Lange U Kumar SC Patel RC Patel YC Patel (2000a)ArticleTitleReceptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activityScience288 154–157OccurrenceHandle1:CAS:528:DC%2BD3cXisVGku7o%3D
M Rocheville DC Lange U Kumar R Sasi RC Patel YC Patel (2000b)ArticleTitleSubtypes of the somatostatin receptor assemble as functional homo- and heterodimersJ Biol Chem275 7862–7869OccurrenceHandle1:CAS:528:DC%2BD3cXitVyltr4%3D
RJ Rodrigues TM Alfaro N Rebola CR Oliveira RA Cunha (2005)ArticleTitleCo-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatumJ Neurochem92 433–441OccurrenceHandle15659214
JM Rodriguez-Frade G del Real A Serrano P Hernanz-Falcon SF Soriano AJ Vila-Coro AM de Ana P Lucas I Prieto AC Martinez M Mellado (2004)ArticleTitleBlocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptorEMBO J23 66–76OccurrenceHandle14685276OccurrenceHandle1:CAS:528:DC%2BD2cXhtVeqtLg%3D
JM Rodriguez-Frade M Mellado AC Martinez (2001)ArticleTitleChemokine receptor dimerization: two are better than oneTrends Immunol22 612–617OccurrenceHandle11698222OccurrenceHandle1:CAS:528:DC%2BD3MXot1Sitbg%3D
DA Roess RD Horvat H Munnelly BG Barisas (2000)ArticleTitleLuteinizing hormone receptors are self-associated in the plasma membraneEndocrinology141 4518–4523OccurrenceHandle11108263OccurrenceHandle1:CAS:528:DC%2BD3cXosVSqsLo%3D
J Roh CL Chang A Bhalla C Klein SY Hsu (2004)ArticleTitleIntermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexesJ Biol Chem279 7264–7274OccurrenceHandle14615490OccurrenceHandle1:CAS:528:DC%2BD2cXht1Cktr0%3D
A Saveanu E Lavaque G Gunz A Barlier S Kim JE Taylor MD Culler A Enjalbert P Jaquet (2002)ArticleTitleDemonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cellsJ Clin Endocrinol Metab87 5545–5552OccurrenceHandle12466351OccurrenceHandle1:CAS:528:DC%2BD38XpslWntLc%3D
M Scarselli F Novi E Schallmach R Lin A Baragli A Colzi N Griffon GU Corsini P Sokoloff R Levenson Z Vogel R Maggio (2001)ArticleTitleD2/D3 dopamine receptor heterodimers exhibit unique functional propertiesJ Biol Chem276 30308–30314OccurrenceHandle11373283OccurrenceHandle1:CAS:528:DC%2BD3MXmtFeht7c%3D
T Schöneberg A Schulz H Biebermann T Hermsdorf H Rompler K Sangkuhl (2004)ArticleTitleMutant G-protein-coupled receptors as a cause of human diseasesPharmacol Ther104 173–206OccurrenceHandle15556674
JC Schwartz J Diaz C Pilon P Sokoloff (2000)ArticleTitlePossible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actionsBrain Res Brain Res Rev31 277–287OccurrenceHandle10719154OccurrenceHandle1:CAS:528:DC%2BD3cXhsleqtrw%3D
MA Schwarzschild K Xu E Oztas JP Petzer K Castagnoli N CastagnoliSuffixJr JF Chen (2003)ArticleTitleNeuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson’s diseaseNeurology61 S55–S61OccurrenceHandle14663012OccurrenceHandle1:CAS:528:DC%2BD3sXptVClt7c%3D
S Shiozaki S Ichikawa J Nakamura S Kitamura K Yamada Y Kuwana (1999)ArticleTitleActions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTPPsychopharmacology (Berl)147 90–95OccurrenceHandle1:CAS:528:DC%2BD3cXpslOisw%3D%3D
I Strömberg P Popoli CE Müller S Ferré K Fuxe (2000)ArticleTitleElectrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatumEur J Neurosci12 4033–4037OccurrenceHandle11069599
TH Svensson (2000)ArticleTitleDysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugsBrain Res Brain Res Rev31 320–329OccurrenceHandle10719159OccurrenceHandle1:CAS:528:DC%2BD3cXhsleqtrk%3D
CJ Swanson TP Blackburn X Zhang K Zheng ZQ Xu T Hokfelt TD Wolinsky MJ Konkel H Chen H Zhong MW Walker DA Craig CP Gerald TA Branchek (2005)ArticleTitleAnxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299Proc Natl Acad Sci USA102 17489–17494OccurrenceHandle16287967OccurrenceHandle1:CAS:528:DC%2BD2MXhtlSqtb3M
S Tanganelli K Sandager Nielsen L Ferraro T Antonelli J Kehr R Franco S Ferré LF Agnati K Fuxe J Scheel-Kruger (2004)ArticleTitleStriatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson’s DiseaseParkinsonism Relat Disord10 273–280OccurrenceHandle15196505OccurrenceHandle1:STN:280:DC%2BD2c3ps1Grtg%3D%3D
S Terrillon T Durroux B Mouillac A Breit MA Ayoub M Taulan R Jockers C Barberis M Bouvier (2003)ArticleTitleOxytocin and vasopressin V1A and V2 receptors form constitutive homo- and heterodimers during biosynthesisMol Endocrinolopy17 677–691OccurrenceHandle1:CAS:528:DC%2BD3sXivFCksro%3D
M Torvinen LB Kozell KA Neve LF Agnati K Fuxe (2004)ArticleTitleBiochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptorJ Mol Neurosci24 173–180OccurrenceHandle15456930OccurrenceHandle1:CAS:528:DC%2BD2cXptVyjs70%3D
M Torvinen D Marcellino M Canals LF Agnati C Lluis R Franco K Fuxe (2005a)ArticleTitleAdenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexesMol Pharmacol67 400–407OccurrenceHandle1:CAS:528:DC%2BD2MXhtVWrsL4%3D
M Torvinen C Torri A Tombesi D Marcellino S Watson C Lluis R Franco K Fuxe LF Agnati (2005b)ArticleTitleTrafficking of adenosine A2A and dopamine D2 receptorsJ Mol Neurosci25 191–200OccurrenceHandle1:CAS:528:DC%2BD2MXktlaiu7c%3D
KE van Holde KI Miller E van Olden (2000)ArticleTitleAllostery in very large molecular assembliesBiophys Chem86 165–172OccurrenceHandle11026681OccurrenceHandle1:CAS:528:DC%2BD3cXlvV2ksbc%3D
HH van Tol JR Bunzow HC Guan RK Sunahara P Seeman HB Niznik O Civelli (1991)ArticleTitleCloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapineNature350 610–614OccurrenceHandle1840645OccurrenceHandle1:CAS:528:DyaK38XhsV2n
HF Vischer R Leurs MJ Smit (2006)ArticleTitleHCMV-encoded G-protein-coupled receptors as constitutively active modulators of cellular signaling networksTrends Pharmacol Sci69 56–63
C Wahlestedt R Hakanson CA Vaz Z Zukowska-Grojec (1990)ArticleTitleNorepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitroAm J Physiol258 R736–R742OccurrenceHandle1969241OccurrenceHandle1:CAS:528:DyaK3cXitFWgsbw%3D
SG Ward K Bacon J Westwick (1998)ArticleTitleChemokines and T lymphocytes: more than an attractionImmunity9 1–11OccurrenceHandle9697831OccurrenceHandle1:CAS:528:DyaK1cXkvF2qsLw%3D
AS Woods (2004)ArticleTitleThe mighty arginine, the stable quaternary amines, the powerful aromatics, and the aggressive phosphate: their role in the noncovalent minuetJ Proteome Res3 478–484OccurrenceHandle15253429OccurrenceHandle1:CAS:528:DC%2BD2cXhvF2hs7k%3D
AS Woods F Ciruela K Fuxe LF Agnati C Lluis R Franco S Ferré (2005)ArticleTitleRole of electrostatic interaction in receptor–receptor heteromerizationJ Mol Neurosci26 125–132OccurrenceHandle16012186OccurrenceHandle1:CAS:528:DC%2BD2MXmtl2ksr8%3D
AS Woods S Ferré (2005)ArticleTitleAmazing stability of the arginine-phosphate electrostatic interactionJ Proteome Res4 1397–1402OccurrenceHandle16083292OccurrenceHandle1:CAS:528:DC%2BD2MXlvVahsb0%3D
K Xu E Bastia M Schwarzschild (2005)ArticleTitleTherapeutic potential of adenosine A(2A) receptor antagonists in Parkinson’s diseasePharmacol Ther105 267–310OccurrenceHandle15737407OccurrenceHandle1:CAS:528:DC%2BD2MXhvVCjt7s%3D
ZQ Xu X Zhang VA Pieribone S Grillner T Hokfelt (1998)ArticleTitleGalanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptorsNeuroscience87 79–94OccurrenceHandle9722143OccurrenceHandle1:CAS:528:DyaK1cXlt1eitLo%3D
A Zangen DH Overstreet G Yadid (1997)ArticleTitleHigh serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatmentJ Neurochem69 2477–2483OccurrenceHandle9375680OccurrenceHandle1:CAS:528:DyaK2sXntlKrur0%3DOccurrenceHandle10.1046/j.1471-4159.1997.69062477.x
M Zoli LF Agnati PB Hedlund XM Li S Ferré K Fuxe (1993)ArticleTitleReceptor–receptor interactions as an integrative mechanism in nerve cellsMol Neurobiol7 293–334OccurrenceHandle7514001OccurrenceHandle1:CAS:528:DyaK2cXktVWjtbc%3D
M Zoli D Guidolin K Fuxe LF Agnati (1996)ArticleTitleThe receptor mosaic hypothesis of the engram: possible relevance of Boolean network modelingInt J Neural Syst7 363–368OccurrenceHandle8968825OccurrenceHandle1:STN:280:DyaK2s7itlGkug%3D%3D
Author information
Authors and Affiliations
Department of Neuroscience, Division of Cellular and Molecular Neurochemistry, Karolinska Institutet, Stockholm, Sweden
K. Fuxe, M. Canals, M. Torvinen & A. Terasmaa
Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, and IRCCS of Venezia, Italy
S. Genedani, G. Leo, D. Guidolin & L. F. Agnati
Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain
M. Canals, D. Marcellino, C. Lluis & R. Franco
Department of Physiology, Faculty of Medicine, University of Malaga, Malaga, Spain
Z. Diaz-Cabiale & J. Narvaez
Department of Cell Biology, School of Science, University of Malaga, Malaga, Spain
A. Rivera
Department of Neurochemistry, University of Stockholm, Stockholm, Sweden
L. Lundstrom & U. Langel
Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, Italy
S. Tanganelli
National Institute on Drug Abuse, IRP, NIH, Department of Health and Human Services, Baltimore, MD, USA
S. Ferré & A. Woods
Department of Anatomy and Human Physiology, University of Padova, Padova, Italy
D. Guidolin
- K. Fuxe
You can also search for this author inPubMed Google Scholar
- M. Canals
You can also search for this author inPubMed Google Scholar
- M. Torvinen
You can also search for this author inPubMed Google Scholar
- D. Marcellino
You can also search for this author inPubMed Google Scholar
- A. Terasmaa
You can also search for this author inPubMed Google Scholar
- S. Genedani
You can also search for this author inPubMed Google Scholar
- G. Leo
You can also search for this author inPubMed Google Scholar
- D. Guidolin
You can also search for this author inPubMed Google Scholar
- Z. Diaz-Cabiale
You can also search for this author inPubMed Google Scholar
- A. Rivera
You can also search for this author inPubMed Google Scholar
- L. Lundstrom
You can also search for this author inPubMed Google Scholar
- U. Langel
You can also search for this author inPubMed Google Scholar
- J. Narvaez
You can also search for this author inPubMed Google Scholar
- S. Tanganelli
You can also search for this author inPubMed Google Scholar
- C. Lluis
You can also search for this author inPubMed Google Scholar
- S. Ferré
You can also search for this author inPubMed Google Scholar
- A. Woods
You can also search for this author inPubMed Google Scholar
- R. Franco
You can also search for this author inPubMed Google Scholar
- L. F. Agnati
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Fuxe, K., Canals, M., Torvinen, M.et al. Intramembrane receptor–receptor interactions: a novel principle in molecular medicine.J Neural Transm114, 49–75 (2007). https://doi.org/10.1007/s00702-006-0589-0
Received:
Accepted:
Published:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative